Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia

Area of Science:

• Molecular Biology
• Oncology
• Epigenetics

Background:

• Acute myeloid leukemia (AML) is a blood cancer driven by epigenetic dysregulation.
• Epigenetic regulators control gene expression by modifying chromatin structure without altering DNA sequence.
• These regulators often interact with non-coding RNAs for target specificity.

Purpose of the Study:

• To explore the role of long non-coding RNAs (lncRNAs) in the epigenetic programming of AML.
• To review evidence supporting lncRNAs' involvement in AML pathogenesis.
• To discuss the potential of lncRNAs as diagnostic, prognostic, and therapeutic targets in myeloid leukemias.

Main Methods:

• Literature review of recent evidence on lncRNAs and AML.
• Analysis of epigenetic mechanisms in cancer.
• Exploration of RNA-DNA interactions in gene regulation.

Main Results:

• lncRNAs are increasingly recognized for their role in guiding epigenetic regulators to specific DNA targets.
• Evidence suggests lncRNAs are integral to the unique epigenetic landscape of AML.
• lncRNAs exhibit potential for specific binding to epigenetic regulators.

Conclusions:

• lncRNAs are postulated to be central to AML's epigenetic programming.
• lncRNAs represent promising candidates for diagnostic, prognostic, and therapeutic strategies in AML.
• Further research into lncRNAs could unlock novel avenues for treating myeloid leukemias.